Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

Summers, Q
October 1989
Thorax;Oct1989, Vol. 44 Issue 10, p831
Academic Journal
No abstract available.


Related Articles

  • Cutaneous Pneumocystis carinii Infection Mimicking Kaposi Sarcoma. Litwin, Margaret A.; Williams, Carmen Myrie // Annals of Internal Medicine;7/1/92, Vol. 117 Issue 1, p48 

    Examines pneumocystis carinii pneumonia in a homosexual man with the acquired immunodeficiency syndrome. Medical condition of the patient; Treatment; Conclusion.

  • Diagnosis of Pneumocystis in Pneumonia by Induced Sputum Technique in Patients without the Acquired Immunodeficiency Syndrome. Masur, Henry; Gill, Vee J.; Ognibene, Frederick P.; Shelhamer, James; Godwin, Cynthia; Kovacs, Joseph A. // Annals of Internal Medicine;11/1/88, Vol. 109 Issue 9, p755 

    Deals with the diagnosis of pneumocystis pneumonia by induced sputum technique in patients without the acquired immunodeficiency syndrome. Mortality of AIDS patients from pneumocystis carinii pneumonia; Development of techniques for sputum specimen collection; Treatment modalities for the disease.

  • Inhaled or Intravenous Pentamidine Therapy for Pneumocystis carinii Pneumonia in AIDS. Soo Hoo, Guy W.; Mohsenifar, Zab; Meyer, Richard D. // Annals of Internal Medicine;8/1/90, Vol. 113 Issue 3, p195 

    Compares inhaled pentamidine with intravenous pentamidine for the treatment of Pneumocystis carinii pneumonia in AIDS. Standard therapy for Pneumocystis carinii pneumonia; Toxicity associated with pentamidine therapy; Characteristics of patients in greater respiratory distress.

  • Comparison of three regimens for the treatment of mild to... Safrin, Sharon; Finkelstein, Dianne M. // Annals of Internal Medicine;5/01/96, Vol. 124 Issue 9, p792 

    Reports on a study to compare the tolerality and efficacy of three oral regimens for the treatment of patients with the acquired immunodeficiency syndrome (AIDS) and pneumocystis carinii pneumonia. Cases of Pneumocystis carinii that were reported to the Centers for Disease Control and...

  • Pneumocystis carinii Pneumonia in the United States. Walzer, Peter D.; Perl, Daniel P.; Krogstad, Donald J.; Rawson, Perry G.; Schultz, Myron G. // Annals of Internal Medicine;Jan74, Vol. 80 Issue 1, p83 

    Provides information on patients with confirmed Pneumocystis carinii pneumonia in the U.S. Nature of P. carinii pneumonia; Efficacy of pentamidine in the treatment of pneumocystis pneumonia; Diagnostic features of P. carinii pneumonia; Frequency of P. carinii pneumonia in patients with selected...

  • Pentamidine Isethionate in the Treatment of Pneumocystis carinii Pneumonia. Western, Karl A.; Perera, David R.; Schultz, Myron G. // Annals of Internal Medicine;Nov70, Vol. 73 Issue 5, p695 

    Presents a study on the use of pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Method of the study; Results and discussion; Conclusion.

  • Oral Atovaquaone Comapred with Intravenous Pentamidine for Pneumocystis carinii Pneumonia in Patients with AIDS. Dohn, Michael N.; Weinberg, Winkler G.; Torres, Ramon A.; Follansbee, Stephen E.; Caldwell, Paul T.; Scott, Janna D.; Gathe, Jr, Joseph C.; Haghighat, Dennis P.; Sampson, James H.; Spotkov, Jared; Deresinski, Stanley C.; Meyer, Richard D.; Lancaster, Daniel J. // Annals of Internal Medicine;8/1/94, Vol. 121 Issue 3, p174 

    Objective: To test the hypothesis that the therapeutic success rate of oral atovaquone is not worse than that of intravenous pentamidine in the primary treatment of mild and moderate Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome and to detect differences...

  • Pneumocystis carinii Pneumonia. Thomas, Simon; O'Doherty, Michael; Kateman, Nigel // BMJ: British Medical Journal (International Edition);1/27/90, Vol. 300 Issue 6719, p211 

    Focuses on the aerosolized pentamidine, a treatment directed against the site of the pneumocystis carinii pneumonia. Effects of aerosolized pentamidine; Study of the use of the treatment as a secondary prophylaxis; Factor that affects the efficacy of aerosolized pentamidine.

  • Pentamidine for the Treatment of Pneumocystis carinii Pneumonia and Other Protozoal Diseases. Pearson, Richard D.; Hewlett, Erik L. // Annals of Internal Medicine;Nov85, Vol. 103 Issue 5, p782 

    Studies the therapeutic use of pentamidine for Pneumocystis carinii pneumonia and other protozoal diseases associated with AIDS. Pharmacology of pentamidine; Mechanism of action of pentamidine; Adverse effects of pentamidine.

  • Inhaled or Reduced-Dose Intravenous Pentamidine for Pneumocystis carinii Pneumonia. Conte Jr., John E.; Hollander, Harry; Golden, Jeffrey A. // Annals of Internal Medicine;Oct87, Vol. 107 Issue 4, p495 

    Presents a study which evaluated inhaled or inhaled pentamidine for the treatment of patients with mild Pneumocystis carinii pneumonia. Diagnostic considerations; Methodology of the study; Results.


Read the Article


Sign out of this library

Other Topics